MedTrace Logo

High Flow Oxygen Therapy Versus Conventional Oxygen Therapy in Cardiac Surgery Patients

NCT03282552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2024-07-31

No results posted yet for this study

Summary

High flow oxygen therapy has been applied after extubation in cardiac surgery patients with uncertain efficacy. The current authors plan to conduct a prospective, randomized, controlled study of nasal high flow therapy (NHF) application with high (60L/min) or low flow (40L/min) oxygen mixture administration versus standard oxygen treatment (Venturi mask) after extubation of patients undergoing elective or non-elective cardiac surgery.

Conditions

  • Hypoxemic Respiratory Failure

Interventions

DEVICE

Nasal Cannula High Flow Oxygen

Nasal Cannula High Flow Oxygenation will be implemented at these study groups . (1st study group, and 2nd study group)

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Spiros Zakynthinos, Professor · National and Kapodistrian University of Athens

  • Spiridon Mentzelopoulos, AssProfessor · National and Kapodistrian University of Athens

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2019-10-01
Completion
2019-10-17

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03282552 on ClinicalTrials.gov